Variant chr3-191329942-TGGG-T details in Genebe, Genetics Data Aggregator

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_178335.3(CCDC50):c.49+231_49+233del variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.23 ( 3460 hom., cov: 0)

Consequence

CCDC50
NM_178335.3 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 2.55

Variant links:

Genes affected

CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]

CCDC50 links:

UTS2B (HGNC:30894): (urotensin 2B) Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

UTS2B links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP6

Variant 3-191329942-TGGG-T is Benign according to our data. Variant chr3-191329942-TGGG-T is described in ClinVar as [Benign]. Clinvar id is 1262490.Status of the report is criteria_provided_single_submitter, 1 stars.

BA1

GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.393 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
CCDC50	NM_178335.3 linkuse as main transcript	c.49+231_49+233del		intron_variant		ENST00000392455.9
UTS2B	NM_198152.5 linkuse as main transcript	c.-665+469_-665+471del		intron_variant		ENST00000340524.10

Ensembl

Gene	Transcript	HGVSc	Effect	TSL	MANE	Appris	UniProt
UTS2B	ENST00000340524.10 linkuse as main transcript	c.-665+469_-665+471del	intron_variant	2	NM_198152.5	P1
CCDC50	ENST00000392455.9 linkuse as main transcript	c.49+231_49+233del	intron_variant	1	NM_178335.3	P3	Q8IVM0-2
CCDC50	ENST00000392456.4 linkuse as main transcript	c.49+231_49+233del	intron_variant	1		A1	Q8IVM0-1
UTS2B	ENST00000432514.5 linkuse as main transcript	c.-832+469_-832+471del	intron_variant	5

Frequencies

GnomAD3 genomes

AF:

0.226

AC:

23298

AN:

102944

Hom.:

3453

Cov.:

show subpopulations

Gnomad AFR

AF:

0.399

Gnomad AMI

AF:

0.0579

Gnomad AMR

AF:

0.217

Gnomad ASJ

AF:

0.118

Gnomad EAS

AF:

0.265

Gnomad SAS

AF:

0.183

Gnomad FIN

AF:

0.0903

Gnomad MID

AF:

0.232

Gnomad NFE

AF:

0.117

Gnomad OTH

AF:

0.204

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome

AF:

0.226

AC:

23322

AN:

103008

Hom.:

3460

Cov.:

AF XY:

0.230

AC XY:

11132

AN XY:

48382

show subpopulations

Gnomad4 AFR

AF:

0.399

Gnomad4 AMR

AF:

0.217

Gnomad4 ASJ

AF:

0.118

Gnomad4 EAS

AF:

0.264

Gnomad4 SAS

AF:

0.184

Gnomad4 FIN

AF:

0.0903

Gnomad4 NFE

AF:

0.117

Gnomad4 OTH

AF:

0.203

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

LINK: link

Submissions by phenotype

not provided

Benign:1

Benign, criteria provided, single submitter

clinical testing

GeneDx

Aug 06, 2019

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

Splicing